Pediatric neurologists are being bombarded with questions from patients and families about medical marijuana, but they’re not convinced of the scientific evidence supporting its use in conditions such as intractable epilepsy. Even if they were, they’re somewhat confused about where they stand legally. But many think that the landscape is about to change. Delegates attending […]
“The results of our open-label trial of Epidiolex in children with Dravet syndrome have been very encouraging and we are excited to begin this important placebo-controlled clinical trial,” stated Orrin Devinsky MD, Professor of Neurology, Neurosurgery, and Psychiatry at NYU School of Medicine, and Principal Investigator of the trial. “As one of the largest epilepsy […]
Initial data from an open-label study in treatment-resistant epilepsy of pharmaceutical-grade cannabidiol — the nonpsychoactive ingredient in marijuana that is believed to be responsible for its antiepileptic action — suggest that it reduces seizure rate by about 30%. The product, said to be 98% pure cannabidiol, in development under the brand name Epidiolex by GW Pharmaceuticals, which […]
Mackenzie Kulawy’s seemingly last hope is medical marijuana. We watched our beautiful little toddler with a quirky smile turn into a zombie at age 4, taking medication that in the end didn’t help her seizures. Then, she experienced withdrawal from being taken off of it – which many adults find difficult.Then going on a very […]
Join David, Mike, Christian, and an electric cast of guests as they talk all things Epilepsy!
Listen on your favorite podcast platform by scanning the QR Code or clicking Here!
